Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Johannes Schetelig*, Liesbeth C. de Wreede, Michel van Gelder, Linda Koster, Juergen Finke, Dietger Niederwieser, Dietrich Beelen, G. J. Mufti, Uwe Platzbecker, Arnold Ganser, Silke Heidenreich, Johan Maertens, Gerard Socie, Arne Brecht, Matthias Stelljes, Guido Kobbe, Liisa Volin, Arnon Nagler, Antonin Vitek, Thomas LuftPer Ljungman, Ibrahim Yakoub-Agha, Marie Robin, Nicolaus Kroeger

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)686-695
Number of pages10
JournalLeukemia
Volume33
Issue number3
DOIs
Publication statusPublished - Mar 2019

Keywords

  • HEMATOPOIETIC-CELL TRANSPLANTATION
  • LONG-TERM SURVIVAL
  • OLDER PATIENTS
  • WORKING GROUP
  • CANCER
  • BLOOD
  • AGE
  • RECOMMENDATIONS
  • SURVIVORSHIP
  • MDS

Cite this